Pearl River Capital’s Twist Bioscience TWST Stock Holding History

Pearl River Capital’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,983	Closed	-$246K	–	583
2021 Q1	$246K	Buy	+1,983	New	+$301K	0.08%	334

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Pearl River Capital's TWST Position: Q2 2021 in Review

Pearl River Capital sold out of Twist Bioscience (TWST) in Q2 2021, closing a stake of 1,983 shares — an estimated $246K sold.

Pearl River Capital first reported a position in TWST in Q1 2021 and held it in 1 quarter. The position peaked at $246K in Q1 2021. 244 funds tracked by Wall St. Rank hold TWST as of Q2 2021.

Pearl River Capital reported no remaining Twist Bioscience position as of Q2 2021 after selling out during the quarter.
Pearl River Capital sold 1,983 Twist Bioscience shares in Q2 2021, an estimated $246K.
Pearl River Capital first reported a position in Twist Bioscience in Q1 2021 and held it in 1 quarter.
Pearl River Capital's Twist Bioscience position peaked at $246K in Q1 2021.
244 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2021.

Based on Pearl River Capital's 13F filing for Q2 2021, filed 13 Aug 2021.